Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21836
Title: | EULAR points to consider for conducting clinical trials in systemic lupus erythematosus |
Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
Keywords: | Antirheumatic Agents/*therapeutic use,*Clinical Trials as Topic/methods/standards,Humans,Lupus Erythematosus, Systemic/*drug therapy,Outcome Assessment (Health Care)/methods,Research Design |
URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/21836 |
ISSN: | 1468-2060 |
Link: | http://www.ncbi.nlm.nih.gov/pubmed/18388158 http://ard.bmj.com/content/68/4/470 |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License